Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Lutsenko

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Klinicheskaia Khirurgiia|January 1, 1993
[Iatrogenic effect of various therapeutic and diagnostic methods on a sick child]A F Mozalevskiĭ, S V Lutsenko
Klinicheskaia Khirurgiia|January 1, 1983
[Pathomorphosis of the liver after cryodestruction (experimental study)]R K Tashchiev, S V Lutsenko
Journal of Drug Targeting|April 10, 2003
Cytotoxic and antitumor activities of doxorubicin conjugates with the epidermal growth factor and its receptor-binding fragmentS V Lutsenko, N B Feldman, S E Severin
Biochemistry. Biokhimiia|May 8, 2003
Molecular mechanisms of tumor angiogenesisS V Lutsenko, S M Kiselev, S E Severin
Progress in Clinical and Biological Research|January 1, 1988
Target-residues of the active site affinity modification are different in E1 and E2 formsK N Dzhandzhugazyan, S V Lutsenko, N N Modyanov
Biochemistry. Biokhimiia|July 29, 2003
Tumor angiogenesis inhibitorsS M Kiselev, S V Lutsenko, S E Severin, et al.
European Journal of Biochemistry|December 12, 1990
Dialdehyde ATP derivative as an affinity modifier of the Na+,K(+)-ATPase active siteL R Bernikov, K N Dzhandzhugazyan, S V Lutsenko, et al.
Free Radical Research|March 29, 2018
ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modificationsN T Moldogazieva, I M Mokhosoev, N B Feldman, et al.
Ortopediia Travmatologiia I Protezirovanie|July 1, 1989
[Prenatal diagnosis of hereditary systemic bone diseases]E Ia Grechanina, I Iu Gordienko, S V Lutsenko, et al.
Bioorganicheskaia Khimiia|March 1, 1992
[Recombinant interleukin-3 expression system in E. coli]S V Lutsenko, A I Gurevich, L R Ptitsyn, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Klinicheskaia Khirurgiia|January 1, 1993
[Iatrogenic effect of various therapeutic and diagnostic methods on a sick child]A F Mozalevskiĭ, S V Lutsenko
Klinicheskaia Khirurgiia|January 1, 1983
[Pathomorphosis of the liver after cryodestruction (experimental study)]R K Tashchiev, S V Lutsenko
Journal of Drug Targeting|April 10, 2003
Cytotoxic and antitumor activities of doxorubicin conjugates with the epidermal growth factor and its receptor-binding fragmentS V Lutsenko, N B Feldman, S E Severin
Biochemistry. Biokhimiia|May 8, 2003
Molecular mechanisms of tumor angiogenesisS V Lutsenko, S M Kiselev, S E Severin
Progress in Clinical and Biological Research|January 1, 1988
Target-residues of the active site affinity modification are different in E1 and E2 formsK N Dzhandzhugazyan, S V Lutsenko, N N Modyanov
Biochemistry. Biokhimiia|July 29, 2003
Tumor angiogenesis inhibitorsS M Kiselev, S V Lutsenko, S E Severin, et al.
European Journal of Biochemistry|December 12, 1990
Dialdehyde ATP derivative as an affinity modifier of the Na+,K(+)-ATPase active siteL R Bernikov, K N Dzhandzhugazyan, S V Lutsenko, et al.
Free Radical Research|March 29, 2018
ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modificationsN T Moldogazieva, I M Mokhosoev, N B Feldman, et al.
Ortopediia Travmatologiia I Protezirovanie|July 1, 1989
[Prenatal diagnosis of hereditary systemic bone diseases]E Ia Grechanina, I Iu Gordienko, S V Lutsenko, et al.
Bioorganicheskaia Khimiia|March 1, 1992
[Recombinant interleukin-3 expression system in E. coli]S V Lutsenko, A I Gurevich, L R Ptitsyn, et al.
Pageof 3